394 related articles for article (PubMed ID: 35125819)
1. Transfusion-transmitted hepatitis E: What we know so far?
Cheung CKM; Wong SH; Law AWH; Law MF
World J Gastroenterol; 2022 Jan; 28(1):47-75. PubMed ID: 35125819
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening.
Harvala H; Hewitt PE; Reynolds C; Pearson C; Haywood B; Tettmar KI; Ushiro-Lumb I; Brailsford SR; Tedder R; Ijaz S
Euro Surveill; 2019 Mar; 24(10):. PubMed ID: 30862338
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis E virus: Blood transfusion implications].
Gallian P; Piquet Y; Assal A; Djoudi R; Chiaroni J; Izopet J; Tiberghien P
Transfus Clin Biol; 2014 Nov; 21(4-5):173-7. PubMed ID: 25267201
[TBL] [Abstract][Full Text] [Related]
4. Effect of Hepatitis E Virus RNA Universal Blood Donor Screening, Catalonia, Spain, 2017‒2020.
Bes M; Costafreda MI; Riveiro-Barciela M; Piron M; Rico A; Quer J; Puig L; Sauleda S
Emerg Infect Dis; 2022 Jan; 28(1):157-165. PubMed ID: 34932460
[TBL] [Abstract][Full Text] [Related]
5. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.
Westhölter D; Hiller J; Denzer U; Polywka S; Ayuk F; Rybczynski M; Horvatits T; Gundlach S; Blöcker J; Schulze Zur Wiesch J; Fischer N; Addo MM; Peine S; Göke B; Lohse AW; Lütgehetmann M; Pischke S
J Hepatol; 2018 Jul; 69(1):36-42. PubMed ID: 29551705
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis E and blood donation safety in selected European countries: a shift to screening?
Domanović D; Tedder R; Blümel J; Zaaijer H; Gallian P; Niederhauser C; Sauleda Oliveras S; O'Riordan J; Boland F; Harritshøj L; Nascimento MSJ; Ciccaglione AR; Politis C; Adlhoch C; Flan B; Oualikene-Gonin W; Rautmann G; Strengers P; Hewitt P
Euro Surveill; 2017 Apr; 22(16):. PubMed ID: 28449730
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.
Hewitt PE; Ijaz S; Brailsford SR; Brett R; Dicks S; Haywood B; Kennedy IT; Kitchen A; Patel P; Poh J; Russell K; Tettmar KI; Tossell J; Ushiro-Lumb I; Tedder RS
Lancet; 2014 Nov; 384(9956):1766-73. PubMed ID: 25078306
[TBL] [Abstract][Full Text] [Related]
8. An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients.
Xu C; Wang RY; Schechterly CA; Ge S; Shih JW; Xia NS; Luban NL; Alter HJ
Transfusion; 2013 Oct; 53(10 Pt 2):2505-11. PubMed ID: 23829163
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients.
Harritshøj LH; Hother CE; Sengeløv H; Daugaard G; Sørensen SS; Jacobsen S; Perch M; Holm DK; Sækmose SG; Aagaard B; Erikstrup C; Hogema BM; Lundgren JD; Ullum H
Int J Infect Dis; 2020 Feb; 91():188-195. PubMed ID: 31756566
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of a transfusion emergent risk: the case of HEV].
Pillonel J; Gallian P; Sommen C; Couturier E; Piquet Y; Djoudi R; Laperche S;
Transfus Clin Biol; 2014 Nov; 21(4-5):162-6. PubMed ID: 25267205
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E, what's the real issue?
Larrue H; Abravanel F; Péron JM
Liver Int; 2020 Feb; 40 Suppl 1():43-47. PubMed ID: 32077607
[TBL] [Abstract][Full Text] [Related]
12. Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016-2020.
Harvala H; Reynolds C; Brailsford S; Davison K
Emerg Infect Dis; 2022 Sep; 28(9):1805-1813. PubMed ID: 35997399
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis E virus in Spanish donors and the necessity for screening.
Rivero-Juarez A; Jarilla-Fernandez M; Frias M; Madrigal-Sanchez E; López-López P; Andújar-Troncoso G; Machuca I; Camacho A; Muñoz-Valbuena P; Rivero A
J Viral Hepat; 2019 May; 26(5):603-608. PubMed ID: 30661278
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.
Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
Euro Surveill; 2016 Sep; 21(35):. PubMed ID: 27608433
[TBL] [Abstract][Full Text] [Related]
16. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
Donnelly MC; Scobie L; Crossan CL; Dalton H; Hayes PC; Simpson KJ
Aliment Pharmacol Ther; 2017 Jul; 46(2):126-141. PubMed ID: 28449246
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.
Hoad VC; Seed CR; Fryk JJ; Harley R; Flower RLP; Hogema BM; Kiely P; Faddy HM
Vox Sang; 2017 Oct; 112(7):614-621. PubMed ID: 28833229
[TBL] [Abstract][Full Text] [Related]
18. Serological and molecular prevalence of hepatitis E virus among blood donors from Uruguay.
Bangueses F; Abin-Carriquiry JA; Cancela F; Curbelo J; Mirazo S
J Med Virol; 2021 Jun; 93(6):4010-4014. PubMed ID: 32592500
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period.
Reekie I; Irish D; Ijaz S; Fox T; Bharucha T; Griffiths P; Thorburn D; Harber M; MacKinnon S; Sekhar M
J Clin Virol; 2018 Oct; 107():1-5. PubMed ID: 30099145
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis E virus and blood transfusion safety.
Bi H; Yang R; Wu C; Xia J
Epidemiol Infect; 2020 Jun; 148():e158. PubMed ID: 32594963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
